Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, non-inferiority trial comparing a nitric oxide releasing solution with a macrolide antibiotic for control of bovine respiratory disease in beef feedlot calves at high-risk of developing respiratory tract disease.
Crepieux T, Miller C, Regev-Shoshani G, Schaefer A, Dorin C, Alexander T, Timsit E. Crepieux T, et al. Among authors: regev shoshani g. Res Vet Sci. 2016 Apr;105:216-21. doi: 10.1016/j.rvsc.2016.02.020. Epub 2016 Feb 23. Res Vet Sci. 2016. PMID: 27033936 Clinical Trial.
Non-inferiority of nitric oxide releasing intranasal spray compared to sub-therapeutic antibiotics to reduce incidence of undifferentiated fever and bovine respiratory disease complex in low to moderate risk beef cattle arriving at a commercial feedlot.
Regev-Shoshani G, McMullin B, Nation N, Church JS, Dorin C, Miller C. Regev-Shoshani G, et al. Prev Vet Med. 2017 Mar 1;138:162-169. doi: 10.1016/j.prevetmed.2015.04.008. Epub 2015 Apr 20. Prev Vet Med. 2017. PMID: 25975664
Effects of nasal instillation of a nitric oxide-releasing solution or parenteral administration of tilmicosin on the nasopharyngeal microbiota of beef feedlot cattle at high-risk of developing respiratory tract disease.
Timsit E, Workentine M, Crepieux T, Miller C, Regev-Shoshani G, Schaefer A, Alexander T. Timsit E, et al. Among authors: regev shoshani g. Res Vet Sci. 2017 Dec;115:117-124. doi: 10.1016/j.rvsc.2017.02.001. Epub 2017 Feb 9. Res Vet Sci. 2017. PMID: 28231472 Clinical Trial.
Gaseous nitric oxide reduces influenza infectivity in vitro.
Regev-Shoshani G, Vimalanathan S, McMullin B, Road J, Av-Gay Y, Miller C. Regev-Shoshani G, et al. Nitric Oxide. 2013 May 31;31:48-53. doi: 10.1016/j.niox.2013.03.007. Epub 2013 Apr 2. Nitric Oxide. 2013. PMID: 23562771 Free PMC article.
17 results